Sign in

CIK 0001130166 · Non-accelerated filer<br>Smaller reporting company

Bio Green Med Solution, Inc.

Sign in to watch
Tickers
BGMS BGMSP
Exchange
Nasdaq, OTC
Industry
Wholesale-Durable Goods, NEC
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
911766850
Phone
908-517-7330
Business address
200 CONNELL DRIVE, SUITE 1500, BERKELEY HEIGHTS, NJ, 07922
Former names
Cyclacel Pharmaceuticals, Inc., XCYTE THERAPIES INC

Securities

  • BGMS Common Stock Nasdaq
  • BGMSP Common stock OTC
  1. 4 Other acquisition 10% owner acquired 467,535 shares (other)
  2. 4 Open-market sale 10% owner sold 112,260 shares at $1.81 ($202,854)
  3. 4 Open-market sale 10% owner sold 242,477 shares at $1.80 ($436,459)
  4. SCHEDULE 13G/A Stake Statement of Beneficial Ownership
  5. 4 Open-market sale 10% owner sold 248,814 shares at $1.80 ($447,865)
  6. 4 Open-market sale 10% owner sold 110,749 shares at $1.83 ($203,114)
  7. SCHEDULE 13G/A Stake Statement of Beneficial Ownership
  8. 4 Open-market sale 10% owner sold 13,111 shares at $1.83 ($23,967)
  9. 4 Open-market sale 10% owner sold 120,250 shares at $2.12 ($254,690)
  10. 4 Open-market sale 10% owner sold 19,858 shares at $1.99 ($39,517)
  11. 4 Open-market sale 10% owner sold 19,595 shares at $1.90 ($37,270)
  12. 4 Open-market sale 10% owner sold 92,352 shares at $3.01 ($277,518)
  13. SCHEDULE 13G/A Stake Statement of Beneficial Ownership
  14. 4 Open-market sale 10% owner sold 108,107 shares at $3.09 ($333,834)
  15. 4 Open-market sale 10% owner sold 95,683 shares at an average $4.33 ($414,295)
  16. 4 Open-market sale 10% owner sold 26,051 shares at $5.50 ($143,281)
  17. 4 Open-market sale 10% owner sold 135,793 shares at $6.00 ($814,758)
  18. 4 Open-market sale 10% owner sold 51,400 shares at $5.26 ($270,261)
  19. SCHEDULE 13G/A Stake Statement of Beneficial Ownership
  20. SCHEDULE 13G/A Stake Statement of Beneficial Ownership

Page 3 of 76 · 1,508 filings